A study released Nov. 10 at the 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco reports that patients receiving an innovative new heart valve benefit from a marked increase in quality of life.
A study released Nov. 10 at the 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco reports that patients receiving an innovative new heart valve benefit from a marked increase in quality of life.